NCT03717142View on ClinicalTrials.gov

Feasibility of the LUM Imaging System for Detection of Cancer to the Brain

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

September 13, 2023

Study Completion Date

June 14, 2024

Conditions
Low Grade Glioma of BrainGlioblastomaMetastasis to Brain
Interventions
COMBINATION_PRODUCT

LUM Imaging System

Patients will be injected with one of 3 study doses of LUM015, or have no LUM015 intervention, and tissue will be imaged in vivo and ex vivo with the LUM imaging device.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

Lumicell, Inc.
All Listed Sponsors
lead

Lumicell, Inc.

INDUSTRY